|
|
|
|
| LEADER |
00000nam a2200000 a 4500 |
| 001 |
739949 |
| 003 |
ICU |
| 005 |
19950904000000.0 |
| 008 |
860213s1982 ne a b 10100 eng u |
| 010 |
|
|
|a 82002433 //r85
|
| 020 |
|
|
|a 0444804013
|
| 035 |
|
|
|a (ICU)BID9508495
|
| 035 |
|
|
|a (OCoLC)8281348
|
| 039 |
0 |
|
|a 2
|b 3
|c 3
|d 3
|e 3
|
| 040 |
|
|
|a DLC
|c DLC
|
| 041 |
0 |
|
|a eng
|
| 050 |
0 |
|
|a RC271.I45
|b N48 1982
|
| 060 |
|
|
|a WI HU444WF v. 3
|a QZ 267 N5325
|
| 082 |
0 |
|
|a 616.99/4061
|2 19
|
| 245 |
0 |
0 |
|a New immunomodulating agents and biological response modifiers /
|c edited by B. Serrou and C. Rosenfeld ; guest editors, J. Wybran and G. Meyer.
|
| 260 |
0 |
|
|a Amsterdam ;
|a New York :
|b Elsevier Biomedical Press ;
|a New York :
|b Sole distributors for the U.S.A. and Canada, Elsevier Science Pub. Co.,
|c 1982.
|
| 300 |
|
|
|a xiii, 164 p. :
|b ill. ;
|c 25 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 440 |
|
0 |
|a Human cancer immunology
|v v. 3
|
| 500 |
|
|
|a "Contains the lectures presented on September 29, 1980 at the Erasme Hospital, University of Brussels by the Tumor Immunology Project Group (TIPG)"--Foreword.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 583 |
1 |
|
|a committed to retain
|c 20170930
|d 20421213
|f HathiTrust
|5 ICU
|
| 650 |
|
0 |
|a Immunotherapy
|x Congresses.
|
| 650 |
|
0 |
|a Biological response modifiers
|0 http://id.loc.gov/authorities/subjects/sh85014187
|
| 650 |
|
0 |
|a Cancer
|x Chemotherapy
|x Congresses.
|0 http://id.loc.gov/authorities/subjects/sh2008100047
|
| 650 |
|
0 |
|a Immune response
|x Regulation
|x Congresses.
|0 http://id.loc.gov/authorities/subjects/sh2008104306
|
| 650 |
|
2 |
|a Neoplasms
|x drug therapy
|
| 650 |
|
2 |
|a Neoplasms
|x immunology
|
| 650 |
|
2 |
|a Adjuvants, Immunologic
|x therapeutic use
|
| 650 |
|
2 |
|a Antineoplastic Agents
|x therapeutic use
|
| 650 |
|
7 |
|a Biological response modifiers.
|2 fast
|0 http://id.worldcat.org/fast/fst00832312
|
| 650 |
|
7 |
|a Cancer
|x Chemotherapy.
|2 fast
|0 http://id.worldcat.org/fast/fst00845327
|
| 650 |
|
7 |
|a Immune response
|x Regulation.
|2 fast
|0 http://id.worldcat.org/fast/fst00967872
|
| 650 |
|
7 |
|a Immunotherapy.
|2 fast
|0 http://id.worldcat.org/fast/fst00968044
|
| 655 |
|
7 |
|a Conference papers and proceedings.
|2 fast
|0 http://id.worldcat.org/fast/fst01423772
|
| 700 |
1 |
0 |
|a Serrou, B.
|q (Bernard)
|0 http://id.loc.gov/authorities/names/n80160374
|1 http://viaf.org/viaf/12385251
|
| 700 |
1 |
0 |
|a Rosenfeld, C.
|q (Claude)
|0 http://id.loc.gov/authorities/names/n77000321
|1 http://viaf.org/viaf/13557926
|
| 903 |
|
|
|a HeVa
|
| 903 |
|
|
|a Hathi
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 9eab4697-e84e-5bbf-9f9e-04a62a58cca1
|s 8db1763d-81b3-5934-b787-653f9ec943f6
|
| 928 |
|
|
|t Library of Congress classification
|a RC271.I45N480 1982
|l ASR
|c ASR-SciASR
|i 5751844
|
| 927 |
|
|
|t Library of Congress classification
|a RC271.I45N480 1982
|l ASR
|c ASR-SciASR
|e CRERAR
|b 24913099
|i 1790674
|
